Advertisement

A Rare Complication of Diffuse Malignant Peritoneal Mesothelioma: Spontaneous Ileal Perforation

  • Orhan Kalaycı
  • Güven Barış CansuEmail author
  • Bengür Taşkıran
  • Özlem Eren
Case Report

Introduction

Malignant mesothelioma is a rare type of malignancy involving the serosal lining of the pleura, pericardium, peritoneum, and tunica vaginalis. It has an incidence of three cases per million per year. It is characterized with poor prognosis. Although most cases arise from the pleura, peritoneum may be the site of origin in 30% [1]. Diffuse malignant peritoneal mesothelioma (DMPM), which is more prevalent in fifth to sixth decades of life, constitutes 90% of mesothelioma involving peritoneum [2, 3]. The clinical picture of DMPM is not clear cut from other cases. Abdominal pain, ascites, abdominal fullness due to masses, or systemic symptoms including malaise, decreased appetite, and weight loss are the most common complaints [4].

Spontaneous perforation of the small intestine due to either direct invasion or metastasis from pleural mesothelioma and DMPM is quite rare in English written literature. We present a case of spontaneous ileal perforation due to direct invasion from...

Notes

References

  1. 1.
    Britton M (2002) The epidemiology of mesothelioma. Semin Oncol 29(1):18–25CrossRefGoogle Scholar
  2. 2.
    Bridda A, Padoan I, Mencarelli R, Frego M (2007) Peritoneal mesothelioma: a review. Med Gen Med 9(2):32Google Scholar
  3. 3.
    Deraco M, Nonaka D, Baratti D, Casali P, Rosai J, Younan R, Salvatore A, Cabras AD AD, Kusamura S (2006) Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion. Ann Surg Oncol 13(2):229–237Google Scholar
  4. 4.
    Manzini Vde P, Recchia L, Cafferata M et al (2010) Malignant peritoneal mesothelioma: a multicenter study on 81 cases. Ann Oncol 21(2):348–353CrossRefGoogle Scholar
  5. 5.
    Alkhayal K (2016) Metastatic malignant pleural mesothelioma masquerading as a case of acute abdomen secondary to small bowel perforation. Ann Saudi Med 36(3):229–231CrossRefGoogle Scholar
  6. 6.
    Salemis NS, Tsiambas E, Gourgiotis S et al (2007) Peritoneal mesothelioma presenting as an acute surgical abdomen due to jejunal perforation. J Dig Dis 8(4):216–221CrossRefGoogle Scholar
  7. 7.
    Gocho K, Isobe K, Kaburaki K, Honda Y, Mitsuda A, Akasaka Y, Shimada N, Takagi K, Homma S (2010) Malignant pleural mesothelioma presenting as an acute surgical abdomen due to metastatic jejunal perforation. Intern Med 49(6):597–601CrossRefGoogle Scholar
  8. 8.
    Navarro Garcia MI, Sanchez Perez A, Vazquez Rojas JL (2015) Jejunal perforation by metastasis of malignant pleural mesothelioma. Arch Bronconeumol 51(7):366–367CrossRefGoogle Scholar
  9. 9.
    Kannerstein M, Churg J (1977) Peritoneal mesothelioma. Hum Pathol 8(1):83–94CrossRefGoogle Scholar
  10. 10.
    Chen HC, Tsai KB, Wang CS, Hsieh TJ, Hsu JS (2008) Duodenal metastasis of malignant pleural mesothelioma. J Formos Med Assoc 107(12):961–964CrossRefGoogle Scholar
  11. 11.
    Acherman YI, Welch LS, Bromley CM, Sugarbaker PH (2003) Clinical presentation of peritoneal mesothelioma. Tumori 89(3):269–273CrossRefGoogle Scholar
  12. 12.
    Boffetta P (2007) Epidemiology of peritoneal mesothelioma: a review. Ann Oncol 18(6):985–990CrossRefGoogle Scholar
  13. 13.
    7Sugarbaker PH, Acherman YI, Gonzalez-Moreno S et al (2002) Diagnosis and treatment of peritoneal mesothelioma: the Washington Cancer Institute experience. Semin Oncol 29(1):51–61Google Scholar
  14. 14.
    Eltabbakh GH, Piver MS, Hempling RE, Recio FO, Intengen ME (1999) Clinical picture, response to therapy, and survival of women with diffuse malignant peritoneal mesothelioma. J Surg Oncol 70(1):6–12CrossRefGoogle Scholar
  15. 15.
    Bani-Hani KE, Gharaibeh KA (2005) Malignant peritoneal mesothelioma. J Surg Oncol 91(1):17–25CrossRefGoogle Scholar
  16. 16.
    Mirarabshahii P, Pillai K, Chua TC, Pourgholami MH, Morris DL (2012) Diffuse malignant peritoneal mesothelioma--an update on treatment. Cancer Treat Rev 38(6):605–612CrossRefGoogle Scholar
  17. 17.
    Comin CE, Saieva C, Messerini L (2007) h-Caldesmon, calretinin, estrogen receptor, and Ber-EP4: a useful combination of immunohistochemical markers for differentiating epithelioid peritoneal mesothelioma from serous papillary carcinoma of the ovary. Am J Surg Pathol 31(8):1139–1148CrossRefGoogle Scholar
  18. 18.
    Cerruto CA, Brun EA, Chang D, Sugarbaker PH (2006) Prognostic significance of histomorphologic parameters in diffuse malignant peritoneal mesothelioma. Arch Pathol Lab Med 130(11):1654–1661Google Scholar
  19. 19.
    Husain AN, Colby TV, Ordonez NG et al (2009) Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med 133(8):1317–1331Google Scholar
  20. 20.
    Ordonez NG (2000) Value of thyroid transcription factor-1, E-cadherin, BG8, WT1, and CD44S immunostaining in distinguishing epithelial pleural mesothelioma from pulmonary and nonpulmonary adenocarcinoma. Am J Surg Pathol 24(4):598–606CrossRefGoogle Scholar
  21. 21.
    Lee M, Alexander HR, Burke A (2013) Diffuse mesothelioma of the peritoneum: a pathological study of 64 tumours treated with cytoreductive therapy. Pathology 45(5):464–473CrossRefGoogle Scholar
  22. 22.
    Chua TC, Yan TD, Morris DL (2009) Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: the Australian experience. J Surg Oncol 99(2):109–113CrossRefGoogle Scholar

Copyright information

© Indian Association of Surgical Oncology 2019

Authors and Affiliations

  1. 1.Department of Surgery, Division of Surgical OncologyYunus Emre State HospitalEskişehirTurkey
  2. 2.Department of Internal Medicine, Division of Endocrinology and MetabolismEskişehir City HospitalEskişehirTurkey
  3. 3.Department of PathologyYunus Emre State HospitalEskişehirTurkey

Personalised recommendations